The goal of this FOA is to establish a stream of scientifically and technologically outstanding assays that can be automated for HTS at an NIH-funded (or other) facility.

NCI: The NCI is especially interested in proposals related to cancer prevention, treatment or response to treatment using imaging agents, molecular markers, or biochemical pathways. Assays pertinent to the mission of NCI should be justified as relevant to cancer and may include any physiology, cell biology or developmental process with the goal of identifying molecules that either perturb the system (e.g., drugs for cancer prevention or treatment) or yield molecular information (e.g., imaging agents).

See full description in NIH Guide: PA-07-320